Quantum Biopharma (QNTM) Cash & Equivalents (QoQ) (2020 - 2026)

Quantum Biopharma (QNTM) Cash & Equivalents (QoQ) (2020 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn -
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn -
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn
7 Belite Bio 62.72 Bn 62.72 Bn -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn
9 Revolution Medicines 37.35 Bn 37.35 Bn -
10 Quantum Biopharma 13.11 Bn 13.10 Bn -

Historic Data

Download Data
DateValue
Mar 31, 2026 127.88%
Dec 31, 2025 327.26%
Sep 30, 2025 -70.22%
Jun 30, 2025 -57.43%
Mar 31, 2025 -41.32%
Dec 31, 2024 92.16%
Sep 30, 2024 -5.64%
Sep 30, 2023 -35.92%
Jun 30, 2023 -38.51%
Mar 31, 2023 -45.69%
Dec 31, 2022 -28.50%
Sep 30, 2022 -24.89%
Jun 30, 2022 10.66%
Mar 31, 2022 -18.96%
Dec 31, 2021 -10.32%
Sep 30, 2021 -8.99%
Jun 30, 2021 -13.33%
Mar 31, 2021 184.39%
Dec 31, 2020 25.15%
Sep 30, 2020 45.03%